Guardion Health Sciences ( (GHSI) ) has issued an announcement.
Guardion Health Sciences, Inc. has initiated a significant corporate shakeup, announcing both the delisting of its common stock from the Nasdaq Capital Market and the appointment of Mark Goldstone as the Interim President and CEO, effective October 18, 2024. This move comes as part of a larger dissolution and liquidation plan following the sale of its Viactiv® brand. Goldstone, with over two decades of healthcare industry experience, takes over from Janet Hall and will be compensated $7,500 monthly for his new roles. As the company prepares for its dissolution, it plans to pay a liquidating dividend to its shareholders, with the exact amount and timing subject to various factors, including the resolution of its liabilities and the sale of remaining assets.
See more insights into GHSI stock on TipRanks’ Stock Analysis page.
